T he US anti-abortion lobby is coming after scientists involved in fetal tissue research. The offensive is putting the safety of investigators at risk and has already shut down studies that use fetal tissue derived from abortions. Research projects aimed at treating infectious and neurodegenerative diseases have been jeopardized or terminated, plans for clinical trials have been derailed, and scientists are losing access to a 'gold standard' cell source that in many cases is irreplaceable by other cell types. If more is not done to defend this vital area of biomedical science, a minority group of anti-abortion extremists may well succeed in extinguishing it in the United States.
Species differences between human and animal cells, and developmental differences between fetal and postnatal cells, mean that human fetal cells are often superior to other cell types in such research areas as vaccines, maternal and infant health, human development, and cell transplantation approaches for tissue regeneration. Research with fetal cells has led to vaccines that have saved millions of lives, and has a long history in the United States. As bioethicist Alta Charo told the US House Select Investigative Panel on Infant Lives, chaired by Representative Marsha Blackburn, at its first hearing on March 2, "Fetal tissue has been used in research in this country since the 1920s, and NIH-funded since the 1950s. It has been deemed ethical by federal review bodies going back a half a century and has been specifically authorized for funding by Congress for a quarter-century [...] . "
Controversy around this research first emerged during the 1980s when the Reagan administration sided with anti-abortion forces in banning federal funding for fetal tissue transplantation, which was being explored to treat diabetes and Parkinson's disease. The ban was lifted in 1993. Last July, fetal tissue research was again thrust into the media spotlight when an anti-abortion group, the Center for Medical Progress (CMP) in Irvine, CA, began releasing videos purportedly showing that Planned Parenthood illegally profits from the sale of fetal tissue. The following month, a corporate intelligence firm determined that some of the videos had been deceptively edited. Investigations sparked by the videos in 12 states have concluded that the allegations against Planned Parenthood are baseless.
This inconvenient truth has done little to quell the furor unleashed by the videos, which has spread beyond efforts to restrict abortion and defund Planned Parenthood into the arena of biomedical science. An increasing number of US states have passed or are considering legislation to prohibit fetal tissue donation or research. In the House, the Republicanled Blackburn panel, created in response to the videos to "get the facts about medical practices of abortion service providers and the business practices of the procurement organizations who sell baby body parts, " is targeting not only abortion providers and tissue-supply companies but also those who use fetal tissue to advance medicine (News Analysis, p. 447). Once again, this research has become ensnared in what Charo has called the "proxy wars" of anti-abortion activists.
The Blackburn panel has sent broad and burdensome requests for
In harm's way
A House panel's witch hunt against fetal tissue research demands a forceful response from the biomedical community.
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